V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007065 | 220002752 | 1.67 | 114 | Curative (C) | 2014-12-07 | 2014-12-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031596 | CARBOPLATIN + PACLITAXEL |
| 220007066 | 220002753 | 1.57 | 85.4 | Curative (C) | null | 2014-01-10 | AML 18 TRIAL | 01 | N | 220031605 | AML18 TRIAL |
| 220007067 | 220002754 | 1.8 | 76.4 | Curative (C) | 2014-06-10 | 2014-07-17 | AML16 DA 3+10 | N | null | 220031606 | AML16 TRIAL |
| 220007068 | 220002755 | 1.68 | 81.3 | Palliative (P) | null | 2013-02-28 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220031607 | IDARUBICIN + TRETINOIN |
| 220007069 | 220002755 | 1.8 | 68 | Palliative (P) | 2018-08-31 | 2018-10-07 | AML16 DA 3+10 | N | N | 220031607 | AML16 TRIAL |
| 220007070 | 220002755 | 1.78 | 94 | Palliative (P) | 2013-09-18 | 2013-11-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031607 | CISPLATIN + GEMCITABINE |
| 220007071 | 220002756 | null | 73.2 | Curative (C) | 2018-06-04 | 2018-06-09 | AML18 PILOT TRIAL | 1 | N | 220031612 | PILOT TRIAL |
| 220007072 | 220002756 | 1.62 | 81.3 | Curative (C) | 2017-09-30 | 2017-09-30 | Idarubicin+Tretinoin Spanish Crse1 | 99 | N | 220031612 | IDARUBICIN + TRETINOIN |
| 220007073 | 220002756 | 2.03 | 59.3 | Curative (C) | 2016-07-06 | 2016-07-12 | AML18 PILOT TRIAL | Y | N | 220031612 | PILOT TRIAL |
| 220007074 | 220002756 | 1.67 | 85.4 | Curative (C) | null | 2014-02-09 | AML 18 TRIAL | Y | N | 220031612 | AML18 TRIAL |
| 220007075 | 220002756 | null | 85 | Palliative (P) | 2015-08-12 | 2015-08-17 | GemCarbo Days 1+8 | N | N | 220031612 | GEMCARBO |
| 220007076 | 220021270 | 1.16 | 83.7 | Curative (C) | null | 2013-12-05 | AML 18 TRIAL | Y | N | 220031623 | AML18 TRIAL |
| 220007077 | 220021270 | null | 55 | Palliative (P) | 2017-09-09 | 2017-10-17 | IDARUBICIN + TRETINOIN | Y | N | 220031623 | IDARUBICIN + TRETINOIN |
| 220007078 | 220002757 | 1.69 | 65.6 | Curative (C) | 2016-06-05 | 2016-06-05 | IDARUBICIN + TRETINOIN | 2 | N | 220031628 | IDARUBICIN + TRETINOIN |
| 220007079 | 220011575 | 1.59 | 50 | Curative (C) | 2013-01-26 | 2013-02-01 | AML18 PILOT TRIAL | Y | Y | 220031631 | PILOT TRIAL |
| 220007081 | 220002759 | 1.65 | 63.2 | Curative (C) | 2017-03-21 | 2017-04-24 | AML16 DA 3+10 | N | N | 220031636 | AML16 TRIAL |
| 220007082 | 220002760 | 1.58 | 105 | Curative (C) | null | 2014-10-14 | AML 18 TRIAL | Y | N | 220031639 | AML18 TRIAL |
| 220007083 | 220002761 | null | 79 | Disease modification (D) | 2017-06-29 | 2017-06-29 | Dasatinib | N | N | 220031644 | DASATINIB |
| 220007084 | 220002761 | 1.6 | 78 | Curative (C) | 2016-12-06 | 2017-01-08 | AML16 DA 3+10 | Y | N | 220031644 | AML16 TRIAL |
| 220007085 | 220002761 | null | null | null | 2017-10-22 | 2017-10-26 | IDARUBICIN + TRETINOIN | 2 | N | 220031644 | IDARUBICIN + TRETINOIN |
| 220007086 | 220002761 | 1.65 | 62.4 | null | 2015-06-05 | 2015-06-05 | GEMCARBO | N | null | 220031644 | GEMCARBO |
| 220007088 | 220002763 | null | 94.6 | Palliative (P) | 2016-05-29 | 2016-06-04 | CARBOPLATIN + PACLITAXEL | N | null | 220031653 | CARBOPLATIN + PACLITAXEL |
| 220007089 | 220002763 | 1.85 | null | Curative (C) | 2014-11-06 | 2014-11-09 | IDARUBICIN + TRETINOIN | N | N | 220031653 | IDARUBICIN + TRETINOIN |
| 220007090 | 220002763 | 1.5 | 60.6 | null | 2013-11-06 | 2013-11-14 | CARBOPLATIN + GEMCITABINE | N | N | 220031653 | GEMCARBO |
| 220007091 | 220002763 | 1.68 | 72 | Curative (C) | 2013-12-26 | 2014-01-02 | AML18 PILOT TRIAL | Y | N | 220031653 | PILOT TRIAL |
| 220007092 | 220002764 | 1.73 | 54.1 | null | 2015-10-26 | 2015-10-26 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220031672 | CISPLATIN + GEMCITABINE |
| 220007093 | 220002765 | 1.73 | 63 | Palliative (P) | 2013-11-15 | 2013-11-27 | GemCarbo Days 1+8 | 2 | N | 220031678 | GEMCARBO |
| 220007094 | 220002765 | 1.69 | 53.3 | Curative (C) | 2013-11-26 | 2013-12-03 | AML16 DA 3+10 | N | N | 220031678 | AML16 TRIAL |
| 220007095 | 220002765 | 1.78 | 84.8 | Palliative (P) | 2016-08-04 | 2016-08-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220031678 | CARBOPLATIN + PACLITAXEL |
| 220007096 | 220002765 | 1.79 | 60.3 | Curative (C) | null | 2015-06-07 | AML 18 TRIAL | N | N | 220031678 | AML18 TRIAL |
| 220007097 | 220002765 | 1.69 | 72.2 | Palliative (P) | 2015-02-07 | 2015-02-12 | Dasatinib | 2 | N | 220031678 | DASATINIB |
| 220007098 | 220002765 | null | 89.6 | Neo-adjuvant (N) | null | 2013-10-12 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031678 | CARBOPLATIN + PACLITAXEL |
| 220007099 | 220002765 | 1.74 | 69.3 | Curative (C) | null | 2013-03-06 | AML 18 TRIAL | 1 | N | 220031678 | AML18 TRIAL |
| 220007100 | 220002766 | 1.61 | 71.45 | Curative (C) | 2014-04-26 | 2014-06-05 | AML16 DA 3+10 | null | N | 220031688 | AML16 TRIAL |
| 220007101 | 220002766 | null | 52 | Curative (C) | 2014-10-15 | 2014-10-15 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220031688 | IDARUBICIN + TRETINOIN |
| 220007102 | 220002766 | 1.84 | 77.7 | Palliative (P) | 2015-01-27 | 2015-02-08 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031688 | IDARUBICIN + TRETINOIN |
| 220007103 | 220002767 | 1.68 | 67 | Palliative (P) | 2015-09-18 | 2015-09-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 220031699 | CARBOPLATIN + PACLITAXEL |
| 220007104 | 220011580 | 1.58 | 66 | Palliative (P) | 2017-01-17 | 2017-01-22 | Dasatinib | N | N | 220031700 | DASATINIB |
| 220007105 | 220002768 | 1.5 | 66 | Curative (C) | 2014-04-05 | 2014-04-06 | AML18 PILOT TRIAL | 1 | N | 220031703 | PILOT TRIAL |
| 220007106 | 220002768 | null | 64.4 | Palliative (P) | 2016-09-02 | 2016-09-02 | Carboplatin + Paclitaxel (weekly) | 02 | N | 220031703 | CARBOPLATIN + PACLITAXEL |
| 220007109 | 220020403 | 1.8 | null | null | 2015-05-16 | 2015-05-16 | GemCarbo Days 1+8 | 02 | N | 220031713 | GEMCARBO |
| 220007110 | 220021272 | 1.86 | 84.9 | Palliative (P) | 2014-02-08 | 2014-02-18 | Dasatinib | 2 | N | 220031716 | DASATINIB |
| 220007111 | 220002769 | 1.6 | 0 | Curative (C) | 2017-12-05 | 2017-12-10 | AML18 PILOT TRIAL | Y | N | 220031718 | PILOT TRIAL |
| 220007112 | 220002770 | 1.85 | 82 | Neo-adjuvant (N) | 2017-08-03 | 2017-08-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031719 | CARBOPLATIN + PACLITAXEL |
| 220007113 | 220002770 | 1.84 | 0 | Curative (C) | 2016-09-08 | 2016-09-08 | AML18 PILOT TRIAL | 1 | N | 220031719 | PILOT TRIAL |
| 220007114 | 220002771 | 1.65 | 45 | Palliative (P) | 2016-03-07 | 2016-03-07 | GemCarbo Days 1+8 | N | N | 220031721 | GEMCARBO |
| 220007115 | 220002772 | 1.64 | 92.2 | Palliative (P) | 2013-05-13 | 2013-05-20 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220031722 | CISPLATIN + GEMCITABINE |
| 220007116 | 220002772 | 1.54 | 82.6 | Palliative (P) | 2014-07-05 | 2014-07-13 | AML16 Low Dose Cytarabine | N | N | 220031722 | AML16 TRIAL |
| 220007117 | 220002773 | 1.59 | 46.5 | Palliative (P) | 2015-03-27 | 2015-03-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031728 | CARBOPLATIN + PACLITAXEL |
| 220007118 | 220002773 | 0 | 83 | Palliative (P) | 2014-12-11 | 2014-12-16 | Dasatinib | 02 | N | 220031728 | DASATINIB |